Drug Trial Radar · NCT06577558
Efficacy and Safety of SR1375 in Adult Patients With CAP
Last checked: Nov 19, 2026Latest source record: Jul 9, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
240
Planned (sponsor's estimate)
Start
Sep 10, 2024
Primary completion
Oct 15, 2025
Study completion Oct 30, 2025
Sponsor
- Lead sponsor
- Shanghai SIMR Biotechnology Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Aug 29, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a phase 2 study to evaluate the efficacy and safety of SR1375 in hospitalized adult patients with CAP. Patients will receive SR1375 or placebo for 8 weeks. The study duration for each patient is up to 10 weeks.
Conditions
- Community-acquired Pneumonia
Interventions
SR1375 capsule 3mg+regular treatmentsDrug
SR1375 capsule 3mg QD orally+CAP regular treatments
SR1375 capsule 1mg+regular treatmentsDrug
SR1375 capsule 1mg QD orally+CAP regular treatments
SR1375 capsule 0.3mg+regular treatmentsDrug
SR1375 capsule 0.3mg QD orally+CAP regular treatments
Placebo capsule+regular treatmentsDrug
Placebo capsule QD orally+CAP regular treatments
Primary outcomes
What the sponsor says the trial is designed to measure.
- National Institute of Allergy and Infectious Diseases-Outcome Study (NIAID-OS) 8-point scale scoreTime frame: Up to Day 28
Locations
29 sites in 1 country. Site status is shown where the registry gives one.
Fuyang People's Hospital
Fuyang, Anhui, China · Recruiting
Peking University Third Hospital
Beijing, Beijing Municipality, China · Recruiting
Zhangzhou Hospital
Zhangzhou, Fujian, China · Recruiting
Gaozhou People's Hospital
Gaozhou, Guangdong, China · Recruiting
The First Affiliated Hospital of Sun Yat-sen University
Guangzhou, Guangdong, China · Recruiting
The Third Affiliated Hospital of Southern Medical University
Guangzhou, Guangdong, China · Recruiting
Nanfang Hospital
Guangzhou, Guangdong, China · Recruiting
The First Affiliated Hospital of Shantou University Medical College
Shantou, Guangdong, China · Recruiting
Yulin First People's Hospital
Yulin, Guangxi, China · Recruiting
The First Hospital of Hebei Medical University
Shijiazhuang, Hebei, China · Recruiting
Daqing Longnan Hospital
Daqing, Heilongjiang, China · Recruiting
Daqing People's Hospital
Daqing, Heilongjiang, China · Recruiting
Shangqiu People's Hospital
Shangqiu, Henan, China · Recruiting
Henan Provincial People's Hospital
Zhengzhou, Henan, China · Recruiting
Yueyang Central Hospital
Yueyang, Hunan, China · Recruiting
Nanjing First Hospital
Nanjing, Jiangsu, China · Withdrawn
Jiangxi Provincial People's Hospital
Nanchang, Jiangxi, China · Recruiting
The First Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China · Recruiting
Yanbian University Affiliated Hospital
Yanbian, Jilin, China · Withdrawn
Dalian Central Hospital
Dalian, Liaoning, China · Recruiting
The Second Hospital of Dalian Medical University
Dalian, Liaoning, China · Recruiting
Weifang Second People's Hospital
Weifang, Shandong, China · Recruiting
Zibo Municipal Hospital
Zibo, Shandong, China · Recruiting
Zhongshan Hospital
Shanghai, Shanghai Municipality, China · Recruiting
Shanghai Tongren Hospital
Shanghai, Shanghai Municipality, China · Recruiting
Shanghai Pulmonary Hospital
Shanghai, Shanghai Municipality, China · Recruiting
West China Hospital of Sichuan University
Chengdu, Sichuan, China · Recruiting
The First Affiliated Hospital of Chengdu Medical College
Chengdu, Sichuan, China · Recruiting
Lishui Central Hospital
Lishui, Zhejiang, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.